Backstory behind diabetes group’s rebrand
The MM+M Podcast episode features Pam Morrisroe detailing the rebranding of a diabetes organization to Breakthrough T1D and its reception. The episode also covers Starboard Value's investment in Pfizer.
The MM+M Podcast episode features Pam Morrisroe detailing the rebranding of a diabetes organization to Breakthrough T1D and its reception. The episode also covers Starboard Value's investment in Pfizer.